Evoke Pharma, Inc. announced that it has received a Notice of Allowance from the USPTO for a patent application covering the use of its GIMOTI® (metoclopramide) nasal spray in patients with moderate ...
SOLANA BEACH, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (EVOK) (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases ...
Evoke Pharma, Inc. announces its commitment to addressing the needs of patients with gastroparesis following the FDA's update indicating that the supply of unapproved domperidone, used internationally ...
Deudomperidone represents a transformative treatment for patients with gastroparesis, for which there is no long-term treatment option currently available.” After readout of the envision3D data, ...
CINCINNATI--(BUSINESS WIRE)--CinRx Pharma, a mosaic of biotechnology companies accelerating transformational new medicines to patients, today announced that the first study participant has been dosed ...
Your stomach has essentially gone on strike, and your diabetes is the reason why. Gastroparesis, which literally means stomach paralysis, is one of the most frustrating and dangerous complications of ...
Magnetic stimulation of a group of nerves key to how our gut and brain communicate may help correct the conversation that goes awry in painful, debilitating diabetic gastroparesis, researchers say.
Metoclopramide is used for the symptomatic treatment of post-operative or chemotherapy-induced nausea and vomiting, gastroesophageal reflux disease and gastroparesis. Metoclopramide is generally ...
Eating small frequent meals is among the dietary strategies that could improve gastric emptying. Recommendations include eating small frequent meals, chewing foods well, and limiting insoluble fiber.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results